Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/1998
05/27/1998CN1038506C Preparation process of acylaminoindole derivatives
05/26/1998US5756664 Genetic engineering of proteins with nucleotide sequences for bones
05/26/1998US5756544 Carboxyalkylethers, formulations, and treatment of vascular diseases
05/26/1998US5756515 Brain disorders; nervous system disorders
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756489 18,19-dinor-vitamin D compounds
05/26/1998US5756488 Comprising (20s,22r)-22-methyl-1alpha,25-dihydroxyvitamin d3
05/26/1998US5756467 Useful in prevention and therapy of obesity and cardiovascular diseases in humans and animals; administering in food and feeds
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756461 Antidiabetic agents using leptin proteins
05/26/1998CA2136823C Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
05/26/1998CA2113856C Antidiabetic agent
05/26/1998CA2057444C Substituted pyridyl-dihydroxy-heptenoic acid and its salts
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021190A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998021184A1 Process for substituted pyridines
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998WO1998020895A1 Use of glp-1 peptides
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020871A1 Visceral fat lowering agent
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2271728A1 Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842925A1 Substituted thiazolidinedione derivatives
05/20/1998EP0842664A1 Zinc-containing compositions for oral administration including a copper compound and an aminoacid
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842169A1 Benzothiophene compounds
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841923A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841911A1 Calcium-containing agent for intestinal phosphate binding and process for producing it
05/20/1998EP0725571A4 Psyllium-enriched dough products and method for making the same
05/20/1998EP0643690B1 Desferrioxamine-b salts and their use as orally effective iron chelators
05/20/1998CN1182415A Terminal carboxy or tetrazole groups containing dialkyl ethers
05/20/1998CN1181968A Hypoglycemic medicine composition
05/19/1998US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
05/19/1998US5753703 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
05/19/1998US5753684 By inhibiting the uptake of urea by macrophages and its conversion to urea
05/19/1998US5753678 Heterocyclic compounds
05/19/1998US5753657 Imidazo 1,2-A! pyrazine-4-one, preparation thereof and drugs containing same
05/19/1998US5753643 Heterocyclic compounds
05/19/1998US5753625 Administering polypeptide
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753253 Composition and method for inducing satiety
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020124A2 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998020005A1 Aryloxypropanolamine derivatives, method of preparation and applications thereof
05/14/1998WO1998020000A2 Substituted 3-benzylpyrazoles
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019998A2 N-substituted 2-cyanopyrrolidines
05/14/1998WO1998019712A1 Methods for regulating angiogenesis
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019688A1 Pharmaceutical composition for treatment of diabetes
05/14/1998WO1998009637A3 Treatment of diabetes
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998CA2270545A1 Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/13/1998EP0841057A2 Phospholipid composition, method of making it and its use
05/13/1998EP0840789A2 Transketolase-related protein
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840604A1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
05/13/1998EP0660707A4 Method of preventing nmda receptor-mediated neuronal damage.
05/13/1998EP0525002B1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS
05/13/1998CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/12/1998US5750701 Heterocyclic ethanolamine derivatives with β-adrenoreceptor agonistic activity
05/12/1998US5750688 Reacting an halogenated amine with an oxybenzoic ester; then a 2-(oxyphenyl-)benzothiophene compound
05/12/1998US5750573 Guanylhydrazones and their use to treat inflammatory conditions
05/12/1998US5750572 Anticoagulants
05/12/1998US5750569 Lowering plasma lipids
05/12/1998US5750538 1,2,5-thiadiazol-4-yl-1-azabicyclic derivatives
05/12/1998US5750524 Administering an sulfamide substituted indan derivative
05/12/1998US5750519 Administering dopamine antagonist and prolactin stimulator
05/12/1998US5750518 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation and rheumatoid arthritis
05/12/1998US5750497 Water solublity
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750176 Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
05/12/1998US5750091 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
05/07/1998WO1998018798A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/07/1998WO1998018786A1 Constrained somatostatin agonists and antagonists
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018758A1 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
05/07/1998WO1998018481A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998WO1998018440A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
05/07/1998WO1998018429A2 A method for lowering plasma levels of lipoprotein(a)
05/07/1998DE19645313A1 Substituierte 3-Benzylpyrazole Substituted 3-benzylpyrazoles
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 1298